Search company, investor...

AGCT

agct.bio

Stage

Seed | Alive

Total Raised

$750K

Last Raised

$750K | 6 yrs ago

About AGCT

Developer of genome editing techniques in therapies of several diseases. The company develops HIV and oncology related therapies. The objective is to develop a method for the treatment of HIV-associated malignancies and HIV infections based on the transplantation of hematopoietic stem cells using site-specific genome editing technology.

Headquarters Location

Lunacharskogo Street 35-51

St. Petersburg, 194291,

Russian Federation

7 911 711 3977

Missing: AGCT's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: AGCT's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing AGCT

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AGCT is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

AGCT Patents

AGCT has filed 9 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Molecular biology
  • DNA
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/20/2020

12/21/2021

Molecular biology, Biotechnology, DNA, Genetics, Molecular biology techniques

Grant

Application Date

2/20/2020

Grant Date

12/21/2021

Title

Related Topics

Molecular biology, Biotechnology, DNA, Genetics, Molecular biology techniques

Status

Grant

Latest AGCT News

Good Game CompanyがApex Legends のアジア最大級のコミュニティ大会「AGCT 10th Season Supported by LaLaport Sakai」を開催

Dec 14, 2022

会場について ららぽーと堺の中⼼に位置する、大規模吹き抜け空間で本格的なイベントが開催できる、屋内型のスタジアムコート「Fansta XROSS STADIUM(ファンスタクロススタジアム)」。スポーツイベントやショータイムのステージとなる「Fansta XROSS STADIUM」には、イベントを観覧しながら飲食を楽しめる「Sakai Food Stadium」が併設され、全体で約2,500㎡の広さを誇ります。中央には国内商業施設の屋内型ビジョンとしては最大級の542インチのメインビジョンも設置し、大迫力のライブビューイングなどもお楽しみいただけます。また、「Fansta XROSS STADIUM」を取り囲むように2階壁面に設置されたリボンビジョンによって、本物のスタジアムさながらの臨場感を演出します。 “This tournament is not affiliated with or sponsored by Electronic Arts Inc.” (このトーナメントは、エレクトロニック・アーツの提携および出資を受けたものではありません) GGCについて

AGCT Frequently Asked Questions (FAQ)

  • Where is AGCT's headquarters?

    AGCT's headquarters is located at Lunacharskogo Street 35-51, St. Petersburg.

  • What is AGCT's latest funding round?

    AGCT's latest funding round is Seed.

  • How much did AGCT raise?

    AGCT raised a total of $750K.

  • Who are the investors of AGCT?

    Investors of AGCT include RBV Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.